| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/24/1999 | CA2326694A1 Galanin receptor galr3 and nucleotides encoding same |
| 06/24/1999 | CA2325368A1 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 06/24/1999 | CA2315785A1 Peptides and nucleic acids derived from eisenia foetida and the use thereof |
| 06/24/1999 | CA2315537A1 Methods to treat undesirable immune responses |
| 06/24/1999 | CA2315527A1 Human phosphatases |
| 06/24/1999 | CA2315295A1 110 human secreted proteins |
| 06/24/1999 | CA2315275A1 P53 regulatory protein called rb18a and uses thereof |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | CA2315251A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 06/24/1999 | CA2315250A1 Antifungal and antibacterial peptides |
| 06/24/1999 | CA2315243A1 Glucagon-like peptide-1 crystals |
| 06/24/1999 | CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | CA2314884A1 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | CA2314821A1 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
| 06/24/1999 | CA2314686A1 Gamma-conopeptides |
| 06/24/1999 | CA2314379A1 Human dendriac and brainiac-3 |
| 06/24/1999 | CA2314319A1 Novel surface protein of neisseria meningitidis |
| 06/24/1999 | CA2314141A1 Glucose regulated gene |
| 06/24/1999 | CA2313649A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | CA2313448A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | CA2313212A1 Modulators of cysteine protease |
| 06/24/1999 | CA2312940A1 Antipicornaviral compounds and methods for their use and preparation |
| 06/24/1999 | CA2309765A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
| 06/24/1999 | CA2228730A1 Styelins |
| 06/23/1999 | EP0924519A2 Process for determining of a dosage regime for thrombin inhibitors |
| 06/23/1999 | EP0924297A1 Sialoadhesin family member-2 (saf-2) |
| 06/23/1999 | EP0924296A2 Methods and means for inducing apoptosis by interference in RNA processing |
| 06/23/1999 | EP0923941A2 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 06/23/1999 | EP0923940A1 Peptide-base immunotherapeutic agent for allergic diseases |
| 06/23/1999 | EP0923939A1 Methods and compositions for the treatment of infection and control of flora |
| 06/23/1999 | EP0923938A1 Immunopotentiators |
| 06/23/1999 | EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/23/1999 | EP0923644A1 G-coupled receptor showing selective affinity for atp |
| 06/23/1999 | EP0923642A1 Active survival domains of igf-ir and methods of use |
| 06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
| 06/23/1999 | EP0923604A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
| 06/23/1999 | EP0923601A2 Librairies of backbone-cyclized peptidomimetics |
| 06/23/1999 | EP0923592A1 Methods for purifying nucleic acids |
| 06/23/1999 | EP0923564A1 Pharmaceutical compounds |
| 06/23/1999 | EP0923553A1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
| 06/23/1999 | EP0923382A1 Compositions of plant carbohydrates as dietary supplements |
| 06/23/1999 | EP0923284A1 Cellular immunogens useful as cancer vaccines |
| 06/23/1999 | EP0733101A4 Glucose responsive insulin secreting beta-cell lines and method for producing same |
| 06/23/1999 | EP0690876B1 Protein kinases |
| 06/23/1999 | EP0689452B1 Composition for oral administration of peptides |
| 06/23/1999 | EP0628639B1 Reconstituted human antibody against human interleukin 6 receptor |
| 06/23/1999 | EP0605522B1 Methods for the production of humanized antibodies |
| 06/23/1999 | EP0598816B1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/23/1999 | EP0496818B1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 06/23/1999 | CN1220701A Lipid kinase |
| 06/23/1999 | CN1220699A Antibodies against interferon alpha/beta receptor |
| 06/23/1999 | CN1220670A Inhibitor and stimulator of stem cell proliferationa and use thereof |
| 06/23/1999 | CN1220609A Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
| 06/23/1999 | CN1220608A Mammalian tolloid-like gene and protein |
| 06/23/1999 | CN1220607A Immunopotentiators |
| 06/23/1999 | CN1220606A P1, P4-dithio-P2,P3-monochloromethylene 5',5'-diadenosine P1,P4-tetraphosphate as antithrombotic agent |
| 06/23/1999 | CN1220270A Improved process for stabilizing proteins |
| 06/23/1999 | CN1043737C Apparatus preparing concentrate of coagulation factors, such as fibrinogen, from blood sample |
| 06/23/1999 | CN1043732C Medicine membrane for curing stomatocace |
| 06/23/1999 | CA2222770A1 Method of treating rheumatoid arthritis with low dose type ii collagen |
| 06/22/1999 | US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells |
| 06/22/1999 | US5914394 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 06/22/1999 | US5914392 Anticarcinogenic/antitumor/antimetastasis/antiarthritic agents; wound healing agents; diagnosis |
| 06/22/1999 | US5914391 Stabilized compositions containing hemoglobin |
| 06/22/1999 | US5914348 Substance FA-70D, process for producing the same, and uses thereof |
| 06/22/1999 | US5914345 Treatment with stimulus to induce altered levels of stress response or hear shock proteins |
| 06/22/1999 | US5914332 Retroviral protease inhibiting compounds |
| 06/22/1999 | US5914319 Antithrombotic agents |
| 06/22/1999 | US5914317 A dna which hybridizes under high stringency conditions to a preferential dna sequence encodes b1k proteins which contains atleast thirty amino acid residues in length; useful for treating dermis disorder such as epidermal bulosis |
| 06/22/1999 | US5914316 Administering topically at the site and time of a vascular injury induced by arterial intervention in said mammal a small but inhibitorily effective amount of tissue factor pathway inhibitor |
| 06/22/1999 | US5914315 Isolated amino acid sequences encoding a kunitz-type inhibitor; anticoagulants for treating deep vein thrombosis |
| 06/22/1999 | US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue |
| 06/22/1999 | US5914313 Antibiotics |
| 06/22/1999 | US5914311 Method for reducing serum lipoprotein (A) concentration |
| 06/22/1999 | US5914269 With phosphorothioate intersugar linkages; for hybridization to messenger rna to prevent translation; antisense/anticarcinogenic/antitumor agents for lung, prostate, colon, and ovarian cancer |
| 06/22/1999 | US5914266 Mammallian sex comb on midleg (mammalian SCM) acts as a tumor suppressor |
| 06/22/1999 | US5914260 Fish pancreatic disease virus |
| 06/22/1999 | US5914258 Human deoxycytidine kinase 2 |
| 06/22/1999 | US5914251 Nucleic acid molecules encoding placental-derived growth factors |
| 06/22/1999 | US5914250 Gene which codes for mutant antibiotic having isoleucine substituted at 4 position of amino acid sequence |
| 06/22/1999 | US5914242 Administering fostriecin or analog to patient after onset of cardiac ischemia |
| 06/22/1999 | US5914238 Materials and methods for detection of breast cancer |
| 06/22/1999 | US5914237 Kinase receptor activation assay |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | US5914127 Isolation and uses of caveolae |
| 06/22/1999 | US5914126 Methods to deliver macromolecules to hair follicles |
| 06/22/1999 | US5914112 Anti-CD18 antibodies in stroke |
| 06/22/1999 | US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin |
| 06/22/1999 | US5914110 Contacting biological fluid sample of the patient suffering from excess immunoglobulins e production in a human with monoclonal antibody or fusion protein and detecting the presence or absence of complex of antibody and interleukin-4 |
| 06/22/1999 | US5914108 Implanting a cellular composition containing greater than 90% human hematopoietic stem cells thy-1+, capable of self-regeneration in a coculture medium and capable of differentiation to members of all hematopoietic lineages |
| 06/22/1999 | US5914106 Interleukin-6 receptor agonists |
| 06/22/1999 | CA2147893C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis .beta. virus activity |
| 06/22/1999 | CA2019614C Antihypertensives and food and drinks |
| 06/22/1999 | CA1340597C Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods |
| 06/20/1999 | CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease |
| 06/20/1999 | CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases |
| 06/19/1999 | WO1999032139A1 Improved interferon polymer conjugates |
| 06/19/1999 | CA2237051A1 Enhanced affinity hyaluronan binding peptides |
| 06/19/1999 | CA2225326A1 A simple and efficient method to prepare technetium-99m labelled peptides |
| 06/19/1999 | CA2225325A1 Hemiasterlin analogs |